Accounting standards

Japonica Partners Kazarian to Testify at US GASB Public Hearing on Government Financial Reporting

Retrieved on: 
Monday, April 19, 2021
Paul Kazarian, Japonica Partners, Financial services, Accounting, Finance, Frankie Kazarian, GASB, United States Generally Accepted Accounting Principles, Governmental accounting, Accounting standards, GASB 34, Governmental Accounting Standards Board

b'WASHINGTON, D.C., April 19, 2021 /PRNewswire/ --On 20 April 2021 at 14:00 EDT, Japonica Partners Chairman and CEO, Paul B. Kazarian, will testify at the US Government Accounting Standards Board (GASB) public hearing on government financial reporting models.\nJaponica\'s Kazarian will speak and answer questions related to Project 3-20 from the perspective of both better public financial management (PFM)and as aninvestor in sovereign bonds.\nKazarian will address the implications of GASB\'sfinancial reporting model exposure draft on US government global financial leadership and national financial security.\nKazarian\'s live testimony can be viewed on Tuesday, 20 April 2021 at 14:00 EDT at: https://www.gasb.org/cs/ContentServer?c=Page&cid=1176163491510&d=&pagena...\nKazarian is also the Chairman and CEO of the Charles & Agnes Kazarian Foundation.\nJaponica Partners: Since 1987, Japonica Partners has built a track record by creating transformational investments with low risk high return.

Key Points: 
  • b'WASHINGTON, D.C., April 19, 2021 /PRNewswire/ --On 20 April 2021 at 14:00 EDT, Japonica Partners Chairman and CEO, Paul B. Kazarian, will testify at the US Government Accounting Standards Board (GASB) public hearing on government financial reporting models.\nJaponica\'s Kazarian will speak and answer questions related to Project 3-20 from the perspective of both better public financial management (PFM)and as aninvestor in sovereign bonds.\nKazarian will address the implications of GASB\'sfinancial reporting model exposure draft on US government global financial leadership and national financial security.\nKazarian\'s live testimony can be viewed on Tuesday, 20 April 2021 at 14:00 EDT at: https://www.gasb.org/cs/ContentServer?c=Page&cid=1176163491510&d=&pagena...\nKazarian is also the Chairman and CEO of the Charles & Agnes Kazarian Foundation.\nJaponica Partners: Since 1987, Japonica Partners has built a track record by creating transformational investments with low risk high return.
  • Japonica\'s culture is to see what others do not see and to use "education-education-education" to accomplish what others believe is impossible.
  • See www.japonica.com\nCharles & Agnes Kazarian Foundation:The Charles & Agnes Kazarian Foundation core competency is to improve public financial management and financial literacy.\n'

GINSMS Announces Audited Financial Results for the Twelve-Month Period Ended December 31, 2020

Retrieved on: 
Friday, March 26, 2021
Accounting, Financial regulation, Financial statements, Corporate finance, International Financial Reporting Standards, Financial services, Accounting standards, International Accounting Standards Board, Institute of Chartered Accountants of India, International Public Sector Accounting Standards, Auditor's report

On February 11, 2021, GINSMS had disclosed through the issuance of a press release unaudited financial results for the three-month and the twelve-month periods ended December 31, 2020 and provided financial forecasts for the 2021 financial year.

Key Points: 
  • On February 11, 2021, GINSMS had disclosed through the issuance of a press release unaudited financial results for the three-month and the twelve-month periods ended December 31, 2020 and provided financial forecasts for the 2021 financial year.
  • This financial disclosure was done in advance of todays filing of the audited financial statements of the Corporation to allow GINSMS ultimate holding company, Beat Holdings Limited (BHL), a public company in Japan, to use certain of GINSMS financial information in the preparation of BHLs financial statements.
  • GINSMS financial information for the twelve-month period ended December 31, 2020 was prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB).
  • The loss per share basic (In Canadian cents) for the three months ended December 31, 2020 remained unchanged.

Creative Realities Reports Fourth Quarter and Full Year 2020 Results

Retrieved on: 
Tuesday, March 9, 2021
Accounting, Financial statements, Corporate finance, Financial services, Accounting systems, GAAP, Generally Accepted Accounting Principles, Generally Accepted Accounting Practice, Accounting standards, Auditor's report

LOUISVILLE, Ky., March 9, 2021 /PRNewswire/ -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX, CREXW), a leading provider of digital marketing solutions, announced its financial results for the year ended December 31, 2020, including the quarter ended as of the same date.

Key Points: 
  • LOUISVILLE, Ky., March 9, 2021 /PRNewswire/ -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX, CREXW), a leading provider of digital marketing solutions, announced its financial results for the year ended December 31, 2020, including the quarter ended as of the same date.
  • Gross profit was $8.1 million for the year endedDecember 31, 2020, a decrease of $5.6 million, or 41%, compared to the same period in 2019.
  • Creative Realities, Inc. prepares its consolidated financial statements in accordance with United States generally accepted accounting principles ("GAAP").
  • Creative Realities, Inc. prepares its consolidated financial statements in accordance with United States generally accepted accounting principles ("GAAP").

Conformis, Inc. Reports Fourth Quarter and Year End 2020 Financial Results

Retrieved on: 
Wednesday, March 3, 2021
GAAP, Generally Accepted Accounting Principles, Generally Accepted Accounting Practice, Accounting, Financial services, Finance, Accounting standards, United States Generally Accepted Accounting Principles

Conformis Hip System sales for 2020, which were all in the United States, were up 26.1% to $2.5 million.

Key Points: 
  • Conformis Hip System sales for 2020, which were all in the United States, were up 26.1% to $2.5 million.
  • Total gross profit decreased $3.0 million to $33.7 million, or 49% of revenue, in 2020, compared to $36.7 million, or 47% of revenue, in 2019.
  • Historically, we see a drop in first quarter revenue compared to the preceding fourth quarter as many health plans reset on January 1.
  • In addition to disclosing financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), the Company provides certain information regarding the Company's financial results or projected financial results on a non-GAAP "constant currency basis."

AppHarvest, Inc. Announces Full-Year 2020 Financial Results

Retrieved on: 
Thursday, February 25, 2021
Accounting, Financial services, Communication, Forward-looking statement, Business, Reconciliation, GAAP, Auditing, Financial statements, Accounting standards, Financial accounting, Auditor's report

The Company believes these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to the Companys financial condition and results of operations.

Key Points: 
  • The Company believes these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to the Companys financial condition and results of operations.
  • Reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the financial tables accompanying this press release.
  • The unavailable information could have a significant impact on the Companys full year 2021 GAAP financial results.
  • If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements.

PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results

Retrieved on: 
Monday, February 22, 2021
Accounting, Generally Accepted Accounting Principles, U.S. Securities and Exchange Commission, GAAP, Regulation, Generally Accepted Accounting Practice, Corporate finance, Accounting standards, Financial statements, United States Generally Accepted Accounting Principles

A conference call and webcast on todays Business Update and Preliminary Fourth Quarter Financial Results will take place at 8:30 AM EST.

Key Points: 
  • A conference call and webcast on todays Business Update and Preliminary Fourth Quarter Financial Results will take place at 8:30 AM EST.
  • All listeners should provide the operator with the conference call name PAVmed, Inc. Business Update Conference Call to join.
  • To supplement our unaudited financial results presented in accordance with U.S. generally accepted accounting principles (GAAP), management provides certain non-GAAP financial measures of the Companys financial results.
  • Non-GAAP financial measures are provided to enhance readers overall understanding of our current financial results and to provide further information for comparative purposes.

Synopsys Posts Financial Results for First Quarter Fiscal Year 2021

Retrieved on: 
Wednesday, February 17, 2021
Accounting standards, GAAP, Bas

Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys' operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal planning and forecasting purposes.

Key Points: 
  • Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys' operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal planning and forecasting purposes.
  • Synopsys' management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP.
  • Based upon our review, our projected normalized annual non-GAAP tax rate remains 16% through fiscal year 2021.
  • Whenever Synopsys uses a non-GAAP financial measure, it provides a reconciliation of the non-GAAP financial measure to the most closely applicable GAAP financial measure.

Alan Skelton Named Director of Research and Technical Activities of the Governmental Accounting Standards Board

Retrieved on: 
Friday, January 29, 2021
Finance, Consulting, Banking, Accounting, Professional services, Accounting, Accounting standards, Financial services, Economy, Governmental Accounting Standards Board, GASB, Governmental accounting, Financial Reporting Council, Accounting Standards Board, Generally Accepted Accounting Principles, GASB 34

The Governmental Accounting Standards Board (GASB) today announced the appointment of Alan Skelton to the role of director of research and technical activities.

Key Points: 
  • The Governmental Accounting Standards Board (GASB) today announced the appointment of Alan Skelton to the role of director of research and technical activities.
  • Mr. Skelton has served on the GASBs advisory group, the Governmental Accounting Standards Advisory Council (GASAC), since 2015 and as its vice chair since 2018.
  • Im very pleased to welcome Alan to the GASB to serve as the director of research and technical activities, said GASB Chair Joel Black.
  • Alan shares my passion for the GASBs mission and brings to this role deep technical expertise and practical experience in governmental accounting and financial reporting.

Sagar Teotia to Conclude Tenure as SEC Chief Accountant

Retrieved on: 
Wednesday, January 13, 2021
Accounting, Accounting standards, Financial services, Economy of the United States, Public Company Accounting Oversight Board, Sarbanes–Oxley Act, Financial Accounting Standards Board, Audit

As Chief Accountant, Mr. Teotia is the principal advisor to the Commission on accounting and auditing matters.

Key Points: 
  • As Chief Accountant, Mr. Teotia is the principal advisor to the Commission on accounting and auditing matters.
  • In addition, as Chief Accountant, Mr. Teotia is responsible for assisting the Commission with discharging its oversight of the Financial Accounting Standards Board (FASB) and the Public Company Accounting Oversight Board (PCAOB).
  • Mr. Teotia was named as the SECs Chief Accountant in 2019 after previously serving as Deputy Chief Accountant.He also previously served as a professional accounting fellow in OCA.
  • It has been an absolute honor to work with so many talented professionals at the SEC, said Mr. Teotia.

Sana Biotechnology Announces Appointments to its Board of Directors

Retrieved on: 
Friday, January 8, 2021
Financial services, Accounting standards, Finance, Financial Accounting Foundation, Governmental Accounting Standards Board, GASB, Financial Accounting Standards Board, Chartered Financial Analyst, Governmental accounting, Accounting

SEATTLE, Jan. 8, 2021 /PRNewswire/ -- Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today that Josh Bilenker, M.D., Alise Reicin, M.D., and Michelle Seitz, CFA, have been appointed to the Sana Board of Directors.

Key Points: 
  • SEATTLE, Jan. 8, 2021 /PRNewswire/ -- Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today that Josh Bilenker, M.D., Alise Reicin, M.D., and Michelle Seitz, CFA, have been appointed to the Sana Board of Directors.
  • Dr. Bilenker trained at the University of Pennsylvania in internal medicine and medical oncology, earning board certification in these specialties.
  • She is a Chartered Financial Analyst (CFA) and past board member of The Financial Accounting Foundation (FAF), the governance board of the Financial Accounting Standards Board (FASB) and the Governmental Accounting Standards Board (GASB).
  • Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients.